Personalis Inc diskutieren
Personalis Inc
WKN: A2PLTK / Symbol: PSNL / Name: Personalis / Aktie / Biotechnologie & medizinische Forschung / ? /
8,72 €
1,63 %
Personalis, Inc. (NASDAQ: PSNL) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $7.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its price target raised by analysts at HC Wainwright from $8.00 to $9.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) is now covered by analysts at Guggenheim. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis, Inc. (NASDAQ: PSNL) had its price target lowered by analysts at HC Wainwright from $9.00 to $8.50. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $8.50 price target on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $6.00 to $11.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its price target raised by analysts at HC Wainwright from $8.50 to $10.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its price target raised by analysts at BTIG Research from $11.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its price target raised by analysts at Guggenheim from $6.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for PSNL provided by MarketBeat
Personalis (NASDAQ:PSNL) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for PSNL provided by MarketBeat
Neueste Beiträge
Plece1982 in Discuss Fintechwerx Intl Software Svcs